European Pharmaceutical Review » Chemotherapy
8 FOLLOWERS
News stories and articles referencing chemotherapy on European Pharmaceutical Review! We're a leading resource for scientists working in late-stage drug development, scale-up, and manufacturing. We ensure that the pharmaceutical and life science community is kept up-to-date with the latest regulation, research, developments, and cutting-edge technological progression.
European Pharmaceutical Review » Chemotherapy
1M ago
The innovative treatment significantly increased survival in patients with malignant pleural mesothelioma, a rare, aggressive cancer, according to Phase III data from UK researchers ..read more
European Pharmaceutical Review » Chemotherapy
2M ago
In its first meeting of 2024, the CHMP recommended a generic medicine for schizophrenia and refused a marketing authorisation (MA) for geographic atrophy ..read more
European Pharmaceutical Review » Chemotherapy
2M ago
European Pharmaceutical Review » Chemotherapy
3M ago
European Pharmaceutical Review » Chemotherapy
3M ago
European Pharmaceutical Review » Chemotherapy
3M ago
European Pharmaceutical Review » Chemotherapy
3M ago
European Pharmaceutical Review » Chemotherapy
3M ago
European Pharmaceutical Review » Chemotherapy
4M ago
In this interview, Innate Pharma’s Yannis Morel, Executive Vice President of product portfolio strategy and business development, delves into the unique advantages of using multi-specific antibodies capable of engaging NK cells against tumours for oncology indications, and shares key data from the company’s ongoing and recent clinical trials ..read more
European Pharmaceutical Review » Chemotherapy
5M ago
The only Fc-silent anti- T-cell immunoreceptor with Ig and ITIM domains (TIGIT) antibody in Phase III for upper GI adenocarcinomas could be the first to market for these cancers ..read more